Lv4
760 积分 2022-12-16 加入
Current therapeutic landscape and future treatment perspectives of MASH
1个月前
已完结
Efficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis: a phase 2, dose-ranging, double-blind, randomised controlled trial
1个月前
已完结
GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight
2个月前
已完结
Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD
3个月前
已完结
Supportive and palliative care for older adults with cancer
3个月前
已关闭
EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis
3个月前
已完结
Persistent Binge Drinking History Associated With Advanced Liver Fibrosis and All‐Cause Mortality in MetALD
4个月前
已完结
Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction-associated steatohepatitis
8个月前
已完结
Identifying and preliminary validating patient clusters in coronary artery bypass grafting: integrating autonomic function with clinical and demographic data for personalized care
10个月前
已完结
Nobiletin Ameliorates Hepatic Lipid Deposition, Oxidative Stress, and Inflammation by Mechanisms That Involve the Nrf2/NF-κB Axis in Nonalcoholic Fatty Liver Disease
11个月前
已完结
皖公网安备34019202002308
